Quantitative LC–MS/MS. 1. Impact of Points across a Peak on the Accuracy and Precision of Peak Area Measurements
Journal of the American Society for Mass Spectrometry · 2023-06-07 · 34 (6) · 1136-1144
DOI: 10.1021/jasms.3c00077 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, published online on 2023-05-04. Written by Wei Zeng and 1 co-authors. Institution: Preclinical Development, MRL, Merck & Co., Inc., West Point, Pennsylvania 19486-0004, United States. Major MEDLINE topics: Tandem Mass Spectrometry. Cited 33 times so far (Crossref); 22 references.
Abstract (original language)
The number of points across a chromatographic peak has long been recognized as a key determinant of the accuracy and precision of the measured peak area. In LC-MS-based quantitation experiments in drug discovery and development, the "rule-of-thumb" has been to use 15 or more points. This "rule" is based on the literature describing chromatographic methods where the goal was to achieve the lowest possible imprecision in the measurements, especially when unknown analytes are being detected. Restricting methods to the requirement of at least 15 points across a peak can be detrimental to the development methods that fully optimize the signal-to-noise ratio for the assay using longer dwell times and/or transition summing. This study aims to show that 7 points across the peak for peaks that are 9 s or less wide provide more than sufficient accuracy and precision for drug quantitation studies. Data from simulated Gaussian curves using a sampling interval of 7 points across the peak gave peak area calculations within 1% of the expected total peak area using the Trapezoidal and Riemann rules and 0.6% for the Simpson rule. Low and high concentration samples (n = 5) were assayed using three different LC methods on three different days on two different instruments (API5000 and API5500). The difference in peak area (%ΔPA) and relative standard deviation of the peak areas (%RSD) was less than ∼5%. No significant difference was observed from the data that were obtained from different sampling intervals, different peak widths, different days, different peak sizes, and different instruments. Three core analytical runs were performed on three different days. In each core run, the lower limit of quantitation (LLOQ, n = 5), low quality control (LQC, n = 5), middle quality control (MQC, n = 5), and high-quality control samples (HQC, n = 5) were processed and run simultaneously with a standard curve. The range of the intra- and interday accuracy and precision for 3 core runs was 98.0-105% and 0.9-3.0% for 7 data points and 97.5-105% and 0.8-4.3% for 17 data points, respectively. No significant difference was observed for the different sampling intervals. The results show a sampling interval of 7 points for peaks up to 9 s wide is sufficient to define a peak accurately and precisely for drug quantitation studies in drug discovery and development.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Preclinical Development, MRL, Merck & Co., Inc., West Point, Pennsylvania 19486-0004, United States.
ORCID profiles: Kevin P Bateman
Cite
APA
Zeng, W., & Bateman, K. P. (2023). Quantitative LC–MS/MS. 1. Impact of Points across a Peak on the Accuracy and Precision of Peak Area Measurements. Journal of the American Society for Mass Spectrometry, 34(6), 1136-1144. https://doi.org/10.1021/jasms.3c00077
Vancouver
Zeng W, Bateman KP. Quantitative LC–MS/MS. 1. Impact of Points across a Peak on the Accuracy and Precision of Peak Area Measurements. Journal of the American Society for Mass Spectrometry. 2023;34(6):1136-1144. doi:10.1021/jasms.3c00077
BibTeX
@article{Zeng2023,
author = {Zeng, Wei and Bateman, Kevin P},
title = {Quantitative LC–MS/MS. 1. Impact of Points across a Peak on the Accuracy and Precision of Peak Area Measurements},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
volume = {34},
number = {6},
pages = {1136--1144},
doi = {10.1021/jasms.3c00077}
}
EUVIMED